Cardiff Oncology, Inc. (CRDF) Form 8-K Material Events
Cardiff Oncology, Inc. (CRDF) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRDF
CIK: 1213037
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerScott Young
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001493152-26-042506 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-26 | — | DEFA14A | 0001193125-26-368287 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-26 | 2026-08-26 | DEF 14A | 0001193125-26-368249 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-14 | 2026-08-14 | PRE 14A | 0001193125-26-352135 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344645 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344545 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002222 | View SEC Doc Filr Page |
| S-8 | 2026-07-21 | — | S-8 | 0001193125-26-310273 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | 4 | 0001193125-26-306083 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | 4 | 0001193125-26-306072 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-14 | 8-K | 0001193125-26-305467 | View SEC Doc Filr Page |
| 424B5 | 2026-07-16 | — | 424B5 | 0001193125-26-305465 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001664708-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001184778-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001370087-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001635493-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001543174-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001393415-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001184778-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001193125-26-267563 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001193125-26-254658 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-27 | 8-K | 0001193125-26-248711 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-19 | 8-K | 0001193125-26-231040 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001213037-26-000013 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001213037-26-000011 | View SEC Doc Filr Page |